Charlie Plauche is a Partner at S3 Ventures. At S3, Charlie’s responsibilities include sourcing and evaluating investments, performing due diligence, and portfolio company management. Charlie currently serves on the boards of S3 portfolio companies Alkami Technology, Tango Health, and Zlien. He also works closely with S3’s investments in Liveoak Technologies and TVA Medical. Previous board duties include Favor Delivery (acquired by H-E-B), Kimbia (acquired by GiveGab) and Pristine (acquired by Upskill).
Prior to S3, Charlie was with Harbert Private Equity Funds, a subsidiary of Harbert Management Corporation. At Harbert, Charlie analyzed and structured leveraged buyouts in the healthcare and manufacturing sectors and assisted with portfolio management. He received his M.B.A. from the McCombs School at the University of Texas in Austin and his B.S. in Finance from the University of Mississippi, where he was a Holmes Scholarship recipient and a Mississippi Eminent Scholar.